Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albrecht Lommatzsch

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Ophthalmology and Therapy|February 6, 2024
Letter to the Editor Regarding "LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration"Salvatore Grisanti, Karl-Ulrich Bartz-Schmidt, Heinrich Heimann, et al.
Retina (Philadelphia, Pa.)|September 24, 2015
CORRELATION OF OPTICAL COHERENCE TOMOGRAPHY AND MACULAR PIGMENT OPTICAL DENSITY MEASUREMENTS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIAMeike B Zeimer, Ferenc B Sallo, Georg Spital, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 5, 2010
Long-term visual course after anti-VEGF therapy for exudative AMD in clinical practice evaluation of the German reinjection schemeBritta Heimes, Albrecht Lommatzsch, Meike Zeimer, et al.
Diagnostics (Basel, Switzerland)|November 26, 2022
The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMDHenrik Faatz, Kai Rothaus, Martin Ziegler, et al.
Die Ophthalmologie|May 22, 2024
[Macular hole: Differential diagnosis, treatment options and new guideline recommendations]Jeany Q Li, Lars-Olof Hattenbach, Albrecht Lommatzsch, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 20, 2021
[Retinal imaging of vitreomacular traction diseases]Ricarda G Schumann, Tina R Herold, Christos Haritoglou, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|December 3, 2020
[Adherence to anti-VEGF treatment-Considerations and practical recommendations]Albrecht Lommatzsch, Nicole Eter, Christoph Ehlken, et al.
Klinische Monatsblatter Fur Augenheilkunde|September 13, 2017
[OCT Angiography in Exudative AMD with Detachment of Vascularised Retinal Pigment Epithelium]Frederic Gunnemann, Kai Rothaus, Marie-Louise Farecki, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 30, 2008
Foveal RPE autofluorescence as a prognostic factor for anti-VEGF therapy in exudative AMDBritta Heimes, Albrecht Lommatzsch, Meike Zeimer, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 28, 2014
The contribution of genetic factors to phenotype and progression of drusen in early age-related macular degenerationMartha Dietzel, Daniel Pauleikhoff, Astrid Arning, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Ophthalmology and Therapy|February 6, 2024
Letter to the Editor Regarding "LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration"Salvatore Grisanti, Karl-Ulrich Bartz-Schmidt, Heinrich Heimann, et al.
Retina (Philadelphia, Pa.)|September 24, 2015
CORRELATION OF OPTICAL COHERENCE TOMOGRAPHY AND MACULAR PIGMENT OPTICAL DENSITY MEASUREMENTS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIAMeike B Zeimer, Ferenc B Sallo, Georg Spital, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 5, 2010
Long-term visual course after anti-VEGF therapy for exudative AMD in clinical practice evaluation of the German reinjection schemeBritta Heimes, Albrecht Lommatzsch, Meike Zeimer, et al.
Diagnostics (Basel, Switzerland)|November 26, 2022
The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMDHenrik Faatz, Kai Rothaus, Martin Ziegler, et al.
Die Ophthalmologie|May 22, 2024
[Macular hole: Differential diagnosis, treatment options and new guideline recommendations]Jeany Q Li, Lars-Olof Hattenbach, Albrecht Lommatzsch, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 20, 2021
[Retinal imaging of vitreomacular traction diseases]Ricarda G Schumann, Tina R Herold, Christos Haritoglou, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|December 3, 2020
[Adherence to anti-VEGF treatment-Considerations and practical recommendations]Albrecht Lommatzsch, Nicole Eter, Christoph Ehlken, et al.
Klinische Monatsblatter Fur Augenheilkunde|September 13, 2017
[OCT Angiography in Exudative AMD with Detachment of Vascularised Retinal Pigment Epithelium]Frederic Gunnemann, Kai Rothaus, Marie-Louise Farecki, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 30, 2008
Foveal RPE autofluorescence as a prognostic factor for anti-VEGF therapy in exudative AMDBritta Heimes, Albrecht Lommatzsch, Meike Zeimer, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 28, 2014
The contribution of genetic factors to phenotype and progression of drusen in early age-related macular degenerationMartha Dietzel, Daniel Pauleikhoff, Astrid Arning, et al.
Pageof 8